FDA Approves LEVOTHYROXINE SODIUM — NorthStar RxLLC

# FDA Approves NorthStar RxLLC's Generic Levothyroxine Sodium The U.S. Food and Drug Administration has approved NorthStar RxLLC's abbreviated new drug application for levothyroxine sodium oral formulation, potentially increasing competition in the thyroid hormone replacement market and providing patients with an additional generic treatment option for hypothyroidism. The approval is expected to expand market choice and could place downward pressure on pricing for this widely prescribed medication.